Rapidly emerging technologies, uncertainty in the capital markets and geopolitical dynamics are buffeting the life science sector. The session will provide expert analysis on the key trends shaping industry investment and innovation in 2024 and beyond.

Scientific and technological advances are transforming the development of new treatments and innovative health products and systems. We'll hear from industry leaders on how AI, machine learning, gene editing, mRNA and other breakthroughs are changing how they do business and bring innovation to patients.

Creating a sustainable, dynamic life science economy requires robust research-industry partnerships, access to funding, ambitious entrepreneurs and generous mentors, and the proper physical and economic infrastructure. The panel will share the secrets of what's worked in successful hubs across the country and explore how we can accelerate our regional momentum and new collaborations.  

Passage of the Inflation Reduction Act and other federal and state proposals carry long-term implications for life science companies, investors, startups and, most importantly, patients. The panel will consider the current and future policy landscape and key issues all sector stakeholders should understand when considering industry growth.

The tri-state region has unparalleled capability in developing cutting-edge therapies for the most debilitating and rare diseases. This includes a thriving "Cellicon Valley" and a national institute for biopharmaceutical manufacturing. Our panel will discuss the unique opportunity to leverage these strengths through a transformational, unprecedented regional collaboration.